EWCZ vs FAT vs SKIN

For growth investors, FAT Brands Inc.

(FAT) is the stronger pick with 23. 4% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). European Wax Center, Inc. (EWCZ) offers the better valuation at 26. 5x trailing P/E (8. 5x forward), making it the more compelling value choice. Analysts rate European Wax Center, Inc. (EWCZ) a "Hold" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, FAT Brands Inc.

(FAT) delivered a total return of -8. 5%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: FAT returned -14. 2% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), European Wax Center, Inc.

(EWCZ) is the lower-risk stock at 1. 46β versus The Beauty Health Company's 2. 00β — meaning SKIN is approximately 37% more volatile than EWCZ relative to the S&P 500. On balance sheet safety, European Wax Center, Inc. (EWCZ) carries a lower debt/equity ratio of 4% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), FAT Brands Inc.

(FAT) is pulling ahead at 23. 4% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -98. 3% for FAT Brands Inc.. Over a 3-year CAGR, FAT leads at 70. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

European Wax Center, Inc.

(EWCZ) is the more profitable company, earning 4. 8% net margin versus -32. 0% for FAT Brands Inc. — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EWCZ leads at 22. 0% versus -8. 8% for FAT. At the gross margin level — before operating expenses — EWCZ leads at 73. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SKIN: 42.

9% to $1. 30.

In this comparison, FAT (100.

0% yield), EWCZ (0. 3% yield) pay a dividend. SKIN does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, FAT Brands Inc.

(FAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (100. 0% yield). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FAT: -14. 2%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EWCZ (Consumer Defensive) and FAT (Consumer Cyclical) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EWCZ is a small-cap quality compounder stock; FAT is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock. FAT pays a dividend while EWCZ, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.